Results 291 to 300 of about 25,153 (346)

Postchemotherapy Histiocyte-Rich Pseudotumor of the Spleen Simulating Residual Disease in a Patient With Non-Hodgkin Lymphoma on FDG PET/CT.

Clinical Nuclear Medicine, 2019
A 64-year-old man was treated with multiagent chemotherapy owing to high-grade non-Hodgkin lymphoma presenting as a bulky disease involving the spleen.
N. Hod, S. Lantsberg, Reut Anconina, D. Levin, K. Nalbandyan, I. Levi   +5 more
semanticscholar   +1 more source

T cell/histiocyte-rich large B-cell lymphoma: an update on its biology and classification

Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin, 2011
Thomas Tousseyn
exaly   +2 more sources

Histiocytic endometritis

Histopathology, 1980
Two cases of histiocytic endometritis are described, both characterized by total replacement of the endometrium with sheets of lipid‐containing histiocytic cells. This condition appears to be a rare complication of cervical occlusion and it is suggested that the histiocytic reaction occurs as a response to a haematometra.
C H, Buckley, H, Fox
openaire   +2 more sources

CD19-directed CART therapy for T-cell/histiocyte–rich large B-cell lymphoma

Blood Advances
Key Points • The 2-year progression-free survival of 58 patients with T-cell/histiocyte–rich large B-cell lymphoma treated with CD19-CART therapy was 29%.
P. Pophali, Josh Fein, Kwang Woo Ahn, Molly Allbee-Johnson, Nausheen Ahmed, Farrukh T Awan, Shatha Farhan, Natalie S Grover, Talal Hilal, M. Iqbal, Joeseph Maakaron, D. Modi, Elham Nasrollahi, L. Schachter, C. Sauter, Medhi Hamadani, Alex F. Herrera, R. Shouval, Mazyar Shadman   +18 more
semanticscholar   +1 more source

Histiocytic Syndromes

Dermatologic Clinics, 1989
The histiocytic syndromes are currently divided into two major categories: Langerhans cell histiocytosis and non-Langerhans cell histiocytosis. The disease entities recognized under these categories are discussed. The discussion includes clinical features, histopathology, and treatment.
S S, Raimer, E, Hollabaugh
openaire   +2 more sources

Permanent consequences in Langerhans cell histiocytosis patients: A pilot study from the Histiocyte Society?Late Effects Study Group

Pediatric Blood and Cancer, 2004
Riccardo Haupt, Maria Grazia Calevo, Kenneth L Mcclain   +2 more
exaly   +2 more sources

2′‐chlorodeoxyadenosine (2‐CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH‐S‐98 protocol of the histiocyte society

Pediatric Blood and Cancer, 2009
Jean Donadieu, Stephan Ladisch
exaly   +2 more sources

Cutaneous true histiocytic malignancy: True histiocytic lymphoma

Journal of the American Academy of Dermatology, 2004
True histiocytic malignancies (THM) are controversial disorders that are being re-evaluated with modern cellular and molecular biology techniques. True histiocytic lymphoma (THL) is a low-incidence, poor-prognosis THM. It mainly affects the skin, gastrointestinal tract, and bone tissues.
Myriam, Chaín, Ignacio, Dei-Cas, Sergio, Carbia, Mariana, Xifra, Dolores, Wright, Roberto, Glorio, Alberto, Devés, Alberto, Woscoff   +7 more
openaire   +2 more sources

Langerhans Cell Histiocytosis: A Review of the Current Recommendations of the Histiocyte Society

Pediatric Dermatology, 2008
E. Satter, W. High
exaly   +2 more sources

Histiocytic medullary reticulosis

The American Journal of Medicine, 1961
Abstract The case presented fulfills the clinical and morphologic requirements of histiocytic medullary reticulosis as laid down by Bodley Scott and Robb-Smith [1]. This invariably and apparently rapidly fatal disease of adults is characterized morphologically by a diffuse proliferation of phagocytic histiocytes and their precursors in lymph nodes ...
F G, ZAK, E, RUBIN
openaire   +2 more sources